Nasonex Adverse Reactions

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Treatment-related local adverse events reported in clinical studies include headache (8%), epistaxis (ie, frank bleeding, blood-tinged mucus and blood fleck) (8%), pharyngitis (4%), nasal burning (2%) nasal irritation (2%) and nasal ulceration (1%), which were typically observed with the use of a corticosteroid nasal spray. Epistaxis was generally self-limiting and mild in severity, and occurred at a higher incidence compared to placebo (5%), but at a comparable or lower incidence compared to active control nasal corticosteroids studied (up to 15%). The incidence of all other effects was comparable with that of placebo.
In the pediatric population, the incidence of adverse effects eg, headache (3%), epistaxis (6%), nasal irritation (2%) and sneezing (2%) was comparable to placebo.

View ADR Monitoring Form

mometasone

Manufacturer:

Organon Pharma Indonesia

Marketer:

Transfarma Medica Indah